Eric A. Weaver

2.6k total citations
68 papers, 2.0k citations indexed

About

Eric A. Weaver is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, Eric A. Weaver has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 31 papers in Genetics and 29 papers in Molecular Biology. Recurrent topics in Eric A. Weaver's work include Virus-based gene therapy research (30 papers), Influenza Virus Research Studies (20 papers) and HIV Research and Treatment (14 papers). Eric A. Weaver is often cited by papers focused on Virus-based gene therapy research (30 papers), Influenza Virus Research Studies (20 papers) and HIV Research and Treatment (14 papers). Eric A. Weaver collaborates with scholars based in United States, Australia and Burkina Faso. Eric A. Weaver's co-authors include Michael A. Barry, Reeti Khare, Christopher Y. Chen, Bette Korber, Feng Gao, Barton F. Haynes, Beatrice H. Hahn, Richard J. Webby, David W. McCurdy and David Kovář and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Eric A. Weaver

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric A. Weaver United States 25 967 740 572 564 500 68 2.0k
Gerald W. Both Australia 27 1.1k 1.1× 1.1k 1.5× 413 0.7× 565 1.0× 250 0.5× 57 2.1k
Nava Sarver United States 23 1.4k 1.4× 653 0.9× 399 0.7× 427 0.8× 614 1.2× 39 2.3k
Yasuko Tsunetsugu‐Yokota Japan 24 872 0.9× 222 0.3× 362 0.6× 519 0.9× 587 1.2× 83 2.4k
Guy Lemay Canada 25 662 0.7× 478 0.6× 271 0.5× 740 1.3× 306 0.6× 80 1.7k
Shawn S. Jackson United States 18 782 0.8× 447 0.6× 279 0.5× 291 0.5× 243 0.5× 34 1.8k
Bertrand Boson France 18 488 0.5× 388 0.5× 621 1.1× 579 1.0× 224 0.4× 35 1.7k
Jerry L. Blackwell United States 20 650 0.7× 638 0.9× 282 0.5× 466 0.8× 449 0.9× 36 1.8k
Reinhold Welker Germany 15 731 0.8× 236 0.3× 379 0.7× 587 1.0× 990 2.0× 19 1.7k
Andrea Cimarelli France 28 968 1.0× 389 0.5× 561 1.0× 813 1.4× 1.6k 3.2× 75 2.6k
Valerie Bosch Germany 20 611 0.6× 288 0.4× 452 0.8× 586 1.0× 883 1.8× 44 1.7k

Countries citing papers authored by Eric A. Weaver

Since Specialization
Citations

This map shows the geographic impact of Eric A. Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Weaver more than expected).

Fields of papers citing papers by Eric A. Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Weaver. The network helps show where Eric A. Weaver may publish in the future.

Co-authorship network of co-authors of Eric A. Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Weaver. A scholar is included among the top collaborators of Eric A. Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Weaver. Eric A. Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weaver, Eric A., et al.. (2024). Multivalent Epigraph Hemagglutinin Vaccine Protects against Influenza B Virus in Mice. Pathogens. 13(2). 97–97. 2 indexed citations
2.
Weaver, Eric A., et al.. (2023). Existing Evidence for Influenza B Virus Adaptations to Drive Replication in Humans as the Primary Host. Viruses. 15(10). 2032–2032. 7 indexed citations
3.
Steffen, David, et al.. (2023). Adenoviral-vectored epigraph vaccine elicits robust, durable, and protective immunity against H3 influenza A virus in swine. Frontiers in Immunology. 14. 1143451–1143451. 7 indexed citations
4.
Lin, Haishuang, Eric A. Weaver, Virginia López, et al.. (2020). Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains. Journal of Biological Chemistry. 295(50). 17114–17127. 8 indexed citations
5.
6.
Gorman, Matthew J., et al.. (2018). Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine. Scientific Reports. 8(1). 18017–18017. 38 indexed citations
7.
Webby, Richard J. & Eric A. Weaver. (2015). Centralized Consensus Hemagglutinin Genes\nInduce Protective Immunity against H1, H3\nand H5 Influenza Viruses. Insecta mundi. 18 indexed citations
8.
Weaver, Eric A., Zenaido T. Camacho, Matthew L. Hillestad, et al.. (2015). Mucosal vaccination by adenoviruses displaying reovirus sigma 1. Virology. 482. 60–66. 5 indexed citations
9.
Camacho, Zenaido T., et al.. (2014). CD46-Mediated Transduction of a Species D Adenovirus Vaccine Improves Mucosal Vaccine Efficacy. Human Gene Therapy. 25(4). 364–374. 11 indexed citations
10.
Guenzel, Adam J., Sean Hofherr, Matthew L. Hillestad, et al.. (2013). Generation of a Hypomorphic Model of Propionic Acidemia Amenable to Gene Therapy Testing. Molecular Therapy. 21(7). 1316–1323. 43 indexed citations
11.
Weaver, Eric A. & Michael A. Barry. (2013). Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines. PLoS ONE. 8(8). e73313–e73313. 40 indexed citations
12.
Chen, Christopher Y., Julien S. Senac, Eric A. Weaver, et al.. (2011). Species D Adenoviruses as Oncolytics against B-cell Cancers. Clinical Cancer Research. 17(21). 6712–6722. 37 indexed citations
13.
Weaver, Eric A., et al.. (2011). Comparison of Adenoviruses as Oncolytics and Cancer Vaccines in an Immunocompetent B Cell Lymphoma Model. Human Gene Therapy. 22(9). 1095–1100. 10 indexed citations
14.
Weaver, Eric A., et al.. (2011). Characterization of species C human adenovirus serotype 6 (Ad6). Virology. 412(1). 19–27. 28 indexed citations
15.
Weaver, Eric A., Adam Rubrum, Richard J. Webby, & Michael A. Barry. (2011). Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin. PLoS ONE. 6(3). e18314–e18314. 50 indexed citations
16.
Weaver, Eric A., Zenaido T. Camacho, & Feng Gao. (2010). Similar T-Cell Immune Responses Induced by Group M Consensus Env Immunogens with Wild-Type or Minimum Consensus Variable Regions. AIDS Research and Human Retroviruses. 26(5). 577–584. 7 indexed citations
17.
Barry, Michael A., Eric A. Weaver, & Sean Hofherr. (2010). Rescue, Amplification, Purification, and PEGylation of Replication Defective First-Generation Adenoviral Vectors. Methods in molecular biology. 651. 227–239. 2 indexed citations
18.
Hofherr, Sean, Elena V. Shashkova, Eric A. Weaver, Reeti Khare, & Michael A. Barry. (2008). Modification of Adenoviral Vectors With Polyethylene Glycol Modulates In Vivo Tissue Tropism and Gene Expression. Molecular Therapy. 16(7). 1276–1282. 81 indexed citations
19.
Nehete, Pramod N., Bharti Nehete, Eric A. Weaver, et al.. (2007). Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine. 25(52). 8687–8701. 47 indexed citations
20.
Liao, Hua-Xin, Laura L. Sutherland, Richard M. Scearce, et al.. (2006). A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology. 353(2). 268–282. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald W. Both Breakdown of academic impact, for papers by Nava Sarver Breakdown of academic impact, for papers by Yasuko Tsunetsugu‐Yokota Breakdown of academic impact, for papers by Guy Lemay Breakdown of academic impact, for papers by Shawn S. Jackson Breakdown of academic impact, for papers by Bertrand Boson Breakdown of academic impact, for papers by Jerry L. Blackwell Breakdown of academic impact, for papers by Reinhold Welker Breakdown of academic impact, for papers by Andrea Cimarelli Breakdown of academic impact, for papers by Valerie Bosch
Rankless by CCL
2026